ERBB2 and cervical carcinoma: Gupta et al. also observed a similar significant HER-2/neu expression in carcinoma cervix, reporting a positivity rate of 63%, with poorly differentiated SCC showing a higher prevalence of HER-2/neu positivity of 80%​ [14].